DANIEL M. CANAFAX
12Patents
1h-index
10Co-inventors
51Inventor score
Filing activity: Sep 17, 2004 → Jan 24, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11395801B2 | Modified release compositions of a gamma-hydroxybutyric acid derivative | Human Necessities | 6 | Active |
| US8114909B2 | Treating or preventing restless legs syndrome using prodrugs of GABA analogs | Human Necessities | 1 | Expired |
| US11944597B2 | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11925710B2 | Modified release compositions of a GAMMA-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US12396956B2 | Modified release compositions of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11690811B2 | Pharmaceutical compositions and oral dosage forms of ketamine derivatives | Human Necessities | 0 | Active |
| US11510892B2 | Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11896573B2 | Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11304906B2 | Controlled release granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
| US12396966B2 | Pharmaceutical compositions and oral dosage forms of ketamine derivatives | Human Necessities | 0 | Active |
| US12337066B2 | Controlled release granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
| US11357734B2 | Pharmaceutical granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.